Pfm Health Sciences, LP Sage Therapeutics, Inc. Transaction History

Pfm Health Sciences, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$25.95 - $43.15 $11.3 Million - $18.8 Million	-436,477 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $11.4 Million - $33.7 Million	436,477 New	436,477 $12.5 Million
Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $22.5 Million - $57.9 Million	-373,828 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $52.4 Million - $71 Million	373,828 New	373,828 $52.4 Million
Q2 2019 Aug 14, 2019	SELL	$157.85 - $183.09 $26.8 Million - $31.1 Million	-169,676 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $30 Million - $55 Million	-336,100 Reduced 66.45%	169,676 $27 Million
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $41.4 Million - $70.7 Million	505,776 New	505,776 $48.4 Million

217

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $428M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.